Survival factors play critical roles in regulating cell growth in normal and cancer cells. We designed a genetic screen to identify survival factors which protect tumor cells from apoptosis. A retroviral expression library of random cDNA fragments was constructed from cancer cells and used to transduce the colon carcinoma cell line HCT116. Recipient cells were functionally selected for induction of caspase 3-mediated apoptosis. Analyses of over 10 000 putative genetic suppression elements (GSEs) sequences revealed cognate gene candidates that are implicated in apoptosis. We further analysed 26 genes encoding cell surface and secreted proteins that can potentially serve as targets for therapeutic antibodies. Tetracycline-inducible GSEs from several gene candidates induced apoptosis in stable HCT 116 cell lines. Similar phenotypes were caused by RNAi derived from the same genes. Our data suggest requirement for the cell surface targets IGF2R, L1CAM and SLC31A1 in tumor cell growth in vitro, and suggests that IGF2R is required for xenograft tumor growth in a mouse model.
Introduction
The fine tuning of signals controlling cell growth and programmed cell death (apoptosis) is essential for cell survival (Hanahan and Weinberg, 2000) . In cancer cells, this signaling is unbalanced due to overexpression or mutation of oncogenes and/or antiapoptotic survival factors. Inhibition of these molecular targets offers a therapeutic opportunity for cancer treatment.
Cell surface receptors and soluble growth factors are amenable to monoclonal antibody therapeutics (mAbs). The mAb technology (Kohler and Milstein, 1975) has resulted in a number of approved antibody treatments for cancer (Carter, 2001) , including trastuzumab (Herceptin s ), a humanized mAb against the receptor tyrosine kinase ErbB2, for ErbB2-overexpressing metastatic breast cancer (Cobleigh et al., 1999) and bevacizumab (Avastin s ), a humanized mAb against the vascular endothelial growth factor, for treatment of metastatic colorectal cancer (Kabbinavar et al., 2003) . In addition to complement-mediated cell lysis, the mechanism of action of Herceptin s , as well as antiepidermal growth factor receptor (EGFR) antibody (Yang et al., 1999) , includes interference with growth factors binding to their receptors and acceleration of receptor internalization thereby inhibiting cancer progression. Some anticancer mAbs promote apoptosis either in cancer cells or in proliferating endothelial cells leading to impaired tumor blood supply. For example, rituximab (Rituxan s ), a mAb against CD20, has been approved for treatment of B-cell non-Hodgkin's lymphoma (Byrd et al., 2002) , and Vitaxint, a mAb against integrin avb3, is currently in Phase I/II clinical trials (Gutheil et al., 2000; Tucker, 2003) . The ability to identify cellular targets, which protect tumor cells from apoptosis, could lead to a more focused development of anticancer therapeutics.
To identify such cell surface and secreted targets, we have used the GSXt System. The GSXt technology allows isolation of genetic suppression elements (GSEs), 100-500 bp biologically active cDNA fragments that interfere with the function of their cognate genes (Roninson et al., 1995; Gudkov and Roninson, 1997) . GSXt functional screens were previously used to identify viral genes that play an important role in the infectious cycle of bacteriophage l (Holzmayer et al., 1992) or human immunodeficiency virus (Dunn et al., 1999) , to clone novel tumor suppressor genes (Garkavtsev et al., 1998) , genes involved in apoptotic response (Neznanov et al., 2003) , genes controlling yeast pheromone response pathway (Caponigro et al., 1998) and genes that modulate cellular response to chemotherapy & 2004 Nature Publishing Group All rights reserved 0950-9232/04 $30.00 www.nature.com/onc ONCOGENOMICS (Gudkov et al., 1994; Gallagher et al., 1997; Levenson et al., 2000; Gros et al., 2003) . Most recently, using GSXt strategy, a large set of genes involved in proliferation of breast carcinoma cells has been identified (Primiano et al., 2003) .
Here, we describe a functional screen for GSEs capable of inducing apoptosis in cancer cells. We have focused on the validation of genes corresponding to cell surface and secreted proteins. Using both stable cell lines with inducible GSE expression and RNAi transfection, we demonstrate the role of several membrane and secretory proteins in proliferation and survival of colon carcinoma cells.
Results

Apoptosis GSE screen design
We have developed a GSE screen to identify genes that regulate cancer cell survival and apoptosis. As illustrated in Figure 1a , the screen was designed to survey the complete cancer cell transcriptomes to select genetic suppressors that activate caspase 3. The screen was conducted in HCT116 colon carcinoma cells for the following reasons: (i) high sensitivity to apoptotic stimuli, (ii) amenability to high-throughput retrovirusmediated gene transfer and (iii) availability of somatic gene knockout derivatives (Torrance et al., 2001) . To Figure 1 Apoptosis GSE screen. (a) Apoptosis GSE screen schematic. 1. Random fragment normalized (equal abundance) cDNA library was prepared from pooled total RNA of eight cancer cell lines and subcloned into IPTG-inducible retroviral vector V99 in an antisense orientation (see panel b). 2. The library was transfected into Phoenix-Eco retrovirus packaging cells to generate viral particles encoding random cDNA fragments. 3. HCT-116 cells were transduced with the viral supernatant. 4. Expression of random cDNA fragments was induced with 50 mM IPTG and floating cells were collected at 0, 24, 48 and 72 h after IPTG induction. Floating cells positive for active caspase-3 were collected. 5. Genomic DNA was isolated from collected cells. Putative GSEs were recovered by PCR and recloned in the V99 vector. 6. The screen was repeated for three iterations. 7. About 10 000 putative GSE clones were sequenced and analysed. (b) Expression vector design. V99 is a modified MoMLV vector containing the coding sequence for a truncated murine CD8a 0 protein, which serves as a marker of viral transduction. An internal CMV promoter, modified by the addition of three lac operons, permits IPTG inducible expression of the random fragment library. The cloning cassette is flanked by rare-restriction sites, sequencing primer sites, unique PCR priming sites and a three-frame TGA sequence. Cell surface and secreted cancer targets MS Gelman et al achieve transcript diversity and minimize bias against differentially expressed genes, we constructed a library of approximately 40 million random cDNA fragments in retroviral expression vector (Figure 1b ) from pooled transcriptomes of eight tumor cell lines. In addition, tumor cell mRNAs were normalized for equal abundance prior to random fragmentation to increase the likelihood of isolating GSEs corresponding to rare messenger RNAs. To ensure selection of potent cytotoxic GSEs, the library expression was controlled by an isopropyl-b-thio-galactoside (IPTG)-regulated CMV promoter (Chang and Roninson, 1996) . We used the processing of caspase 3 zymogen as an apoptotic marker to select GSEs that initiate apoptotic programme. Cells containing active caspase 3 were detected by antibody staining, flow sorted, and subsequent GSE screen hits were isolated from genomic DNA and sequenced. We have determined that induction of apoptosis by a variety of stimuli in HCT116 cells causes more than 85% of apoptotic cells to float (data not shown). Therefore, to increase the throughput of the screen we selected caspase 3-positive cells from the floating cell population (Figure 1c ). To capture GSEs with different expression kinetics, cells were harvested at 0, 24, 48 and 72 h post IPTG treatment. Approximately 5% of cells transduced with empty vector exhibited caspase 3-dependent apoptosis (data not shown). Approximately 1.5 Â 10 9 , 1.9 Â 10 8 and 3.8 Â 10 7 cells transduced with GSE library were passed through the first, second and third consecutive rounds of selection for caspase 3-positive cells, respectively. After the third round of selection, over 10 000 library clones were isolated and sequenced, and subsequent GSE screen hits that induce apoptosis were identified.
Apoptogenic GSE screen hits derived from the genes encoding extracellular proteins
The isolated putative GSEs were derivatives of a diverse group of approximately 950 genes. While the majority of GSE screen hit sequences corresponded to known mRNA sequences (74%), we also identified numerous putative GSE sequences found only in genomic DNA and EST Genbank sequences (26%). As shown in Figure 1d , in many cases, we identified a single putative GSE per gene that are likely to represent nonspecific DNA fragments. High incidence of single GSE screen hits may also suggest that either the screen was not saturated or certain transcripts were under represented in the library. Therefore, single GSE screen hits were excluded from the Figure 1 Continued subsequent studies and cognate genes identified by two or more putative GSE sequences were considered as bona fide hits. Multiple GSE screen hits were enriched for approximately 363 genes encoding cell surface receptors, signaling proteins, transcription factors and other proteins. Approximately 21% of the putative GSEs were derived from genes with unknown function.
Since extracellular targets are amenable for therapeutic antibody development, we focused our analyses on cell surface and secreted proteins. In total 25 genes in this category were identified by two or more putative GSEs (Table 1) . We have included in the study the insulin-like growth factor II receptor/mannose-6-phosphate receptor (IGF2R) gene (which yielded a single antisense putative GSE in our apoptosis screen) since it was previously shown to promote apoptosis in different cancer cell models (Souza et al., 1999; Chen et al., 2002) .
Typically, isolation of clusters of putative GSEs represented by overlapping sequences (termed multiple overlapping elements) is indicative of a strong selection within a particular region of the mRNA. Multiple overlapping elements were found for 12 out of 26 genes ( Table 1) . Most of the isolated putative GSEs were antisense elements, while some were found in a sense orientation (COL4A2 and CD81).
GSE target genes are expressed in tumor cell lines
To confirm the expression of the putative GSE cognate genes in the GSE screen cell model, we performed mRNA expression analysis on HCT116 cell lines using custom Agilent oligonucleotide microarrays. For the 26 cognate genes, two different oligonucleotides were spotted in triplicate on each array. These oligonucleotides differed from one another in their complementary region on the target mRNA, although both regions were located within terminal 1500 nucleotides of the target mRNA. All 26 loci showed expression in HCT116 cells, albeit at low to moderate levels, indicating the presence of cognate transcripts for each of the putative GSEs isolated in the apoptosis screen ( Table 1) .
The same custom Agilent oligonucleotide microarrays were used to further compare the relative expression levels of five cognate genes, XPR1, FBN2, IGF2R, COL4A2 and SLC31A1, in tumor cell lines SKOV3, PC3, A549, MDA-MB-231 and HCT116. Each of the five genes generated a detectable signal in each of the five tumor lines (data not shown). Aside for the relatively strong expression of COL4A2 in SKOV3 cells, the expression profile of each loci was quite similar among the five cell lines examined.
We have assessed protein expression levels of three cognate genes, XPR1, IGF2R and COL4A2, in the same panel of five tumor cell lines using immunocytometry Relative mRNA expression determined by Agilent microarray hybridization. Average intensity of the signal for a specific oligonucleotide probe 1 and probe 2 was normalized to the average intensity of the signal from the two b-2-microglobulin (B2M) probes
Cell surface and secreted cancer targets MS Gelman et al (data not shown). XPR1 protein expression was detected at low levels in all cell lines except A549. IGF2R protein is expressed at a low level in all five cell lines. COL4A2 protein is expressed in low to moderate levels in all cell lines with considerably higher expression in SKOV3 cells.
Apoptogenic GSEs inhibit tumor cell survival and proliferation
To determine whether expression of individual putative GSEs identified in the apoptosis screen can be deleterious to cell survival and proliferation, we have generated stable cell lines with inducible expression of putative GSEs corresponding to the cell surface adhesion protein L1CAM, IGF2R and a copper transporter SLC31A1. As a positive control for this set of experiments, we established a line expressing 1.5 kB c-ErbB2 cDNA fragment cloned in an antisense orientation into the same construct in place of a GSE. This ErbB2 antisense sequence was previously shown to downmodulate endogenous ErbB2 expression and inhibit anchorageindependent growth of ovarian carcinoma cells (Pegues and Stromberg, 1997) . GSE screen hits were cloned into a bicistronic tetracycline-inducible plasmid vector downstream from the hrGFP-IRES cassette. By measuring RNA levels, we have confirmed that expression of GFP correlates linearly with the putative GSE RNA expression (data not shown). Therefore, we used GFP fluorescence as expression marker for putative GSEs. To isolate cell populations enriched for GFP and consequently putative GSE expressors, cells were treated for 16 h with doxycycline and FACS sorted to over 95% purity. Interestingly, after 2 weeks of expansion of sorted cells in the absence of doxycycline, only vector and putative IGF2R GSE cell lines retained GFP inducibility by doxycycline ( Figure 2a , 0-h time point), whereas the rest of the cell lines had lost GFP inducibility in significant portion of their populations (Figure 2a ), suggesting that putative GSE expression is cytotoxic. Upon further treatment with doxycycline for 2 more weeks, percentage of GFP-positive cells continued to decrease in SLC31A1 putative GSE cell line, as well as in c-ErbB2 antisense control line, whereas GFP expessing subpopulation remained relatively stable, albeit low, in L1CAM cell line.
To evaluate the ability of individual putative GSEs to induce apoptosis in host cells, we have examined the activation of caspase 3 in the putative GSE cell lines after 48 h of doxycycline treatment ( Figure 2b ). Increase of 1.5-fold or greater in caspase 3 activation over vector control was detected in GFP-positive subpopulations of the cell lines expressing putative L1CAM and SLC31A GSEs. A small increase in caspase 3-positive cells was seen in these cells even in absence of doxycycline. No significant apoptosis induction was observed in IGF2R and c-ErbB2 antisense cells.
Next, we have examined short-term growth curves of the cell lines using Alamar blue assay (Figure 2c, d) . As shown in Figure 2d , vector and IGF2R cell lines and cells expressing ErbB2 antisense exhibited proliferation rates similar to vector control. However, in the SLC31A1 cell line, proliferation was inhibited by more than 25% as early as 48 h post doxycycline induction (Table 3) . SLC31A1 cells had plating efficiency similar to vector control cells as compared to other cell lines (Figure 2c ), indicating a role for SLC31A1 in cell proliferation.
Furthermore, the plating efficiencies of SLC31A1 cells in soft agar is rather similar to vector control cells (Figure 2e ), whereas IGF2R and ErbB2 antisense cells exhibited very low plating efficiency. Interestingly, several clones derived from IGF2R putative GSE cell lines grew on soft agar independently of doxycycline treatment. In contrast, all other cell lines including ErbB2 antisense cells demonstrated doxycycline-dependent decrease in colony number (Figure 2e ). To correlate colony size to GFP expression, the soft agar colonies were further examined under fluorescent microscope ( Figure 2f ). We found that in the case of vector control, most large colonies were highly fluorescent after exposure to doxycycline. However, in GSE cell lines, only very small colonies were fluorescent, and a substantial fraction of those colonies have lost the GFP fluorescence in the part of colony suggesting GSE cytotoxicity.
To determine whether the observed functional effects of inducible GSEs are due to downmodulation of their cognate genes, we analysed the IGF2R protein expression by immunocytometry upon induction of GSE expression. Figure 3 shows that IGF2R GSE has a slight downmodulation effect on IGF2R surface expression in HCT116 cells. We were unable to verify downmodulation of SLC31A1 protein because no commercial antibody against this protein is currently available. Overall, the combined data obtained with inducible GSE cell lines corroborate the conclusion that expression of L1CAM, SLC31A1 and IGF2R GSEs impairs tumor cell survival and/or proliferation.
Cognate gene silencing by siRNA induce apoptosis
To confirm the doxycycline-inducible GSE phenotypes by independent gene silencing approach, we have designed siRNA inhibitors for L1CAM, SLC31A1 and IGF2R genes (Table 2) . Target siRNAs were transiently transfected into HCT116 cells and their effects on cell survival were analysed using caspase 3 and annexin V assays. Transfection conditions were optimized to ensure at least 77% efficiency in HCT116 cells. Apoptosis induction of fourfold or greater over control (cells transfected with scrambled siRNA and exhibiting 3% active caspase 3-positive cells) was detected for all three siRNAs (Figure 4a , Table 3 ). The most potent inducer of apoptosis was siRNA directed against L1CAM, a cell surface protein that plays an important role in axon guidance during nervous system development, and which has been recently suggested to contribute to the development and progression of human malignant melanoma (Fogel et al., 2003) . A role for L1CAM in cancer is described in a separate manuscript (Suhy et al., submitted). Downmodulation of the L1CAM protein expression by respective siRNA has been detected ( Figure 4b ). Comparable apoptogenic activity was detected with siRNAs directed against IGF2R and SLC31A1. In case of IGF2R siRNA, a significant inhibition of target protein expression was also observed (Figure 4b ).
Annexin V assay of HCT116 cells transfected with the same siRNAs has revealed apoptosis induction of about twofold over control (cells transfected with scrambled siRNA and exhibiting 11% annexin V-positive cells) for SLC31A1 siRNA (Figure 4a, Table 3) . Surprisingly, transfection with siRNAs against L1CAM and IGF2R while causing detectable caspase 3 activation did not score in a more sensitive phosphatidylserine externalization annexin V assay. This effect could be due to variations in apoptotic response and/or kinetics induced by different siRNAs. Overall, all three target genes were confirmed by siRNA inducing apoptosis detectable by at least one assay.
IGF2R GSE inhibits HCT116 tumor growth in xenograft mouse model
We have further studied the effect of IGF2R GSE on tumor growth in HCT116 xenograft mouse tumor model. HCT116 cells expressing tetracycline-inducible IGF2R GSE were implanted in mice and allowed to form tumors. Upon tumor formation half of the animals were treated by doxycycline while the other half were kept untreated. Tumor growth was monitored for about 30 days under a continuous doxycycline treatment. Figure 5 ). In contrast, HCT116 cells expressing ErbB2 antisense construct showed inhibition of tumor growth independent of doxycycline induction. This is most likely due to a leakage in the transgene expression in the absence of doxycycline. These data indicate that IGF2R may play a role in tumor growth in vivo.
Discussion
Genes that play key roles in regulating cell growth and apoptosis could be used as molecular targets for cancer therapeutics. We developed a genomic screen to select target genes for induction of apoptosis in cancer cells. By making a fragmented transcriptome library, we were able to survey large number of genes and to select key genes that are implicated in apoptosis.
In an attempt to achieve screen saturation we have analysed over 10 9 cells transduced with the library during the first iteration of the screen representing at least 20 library complexities. A significant number of multiple GSE screen hits per cognate gene were identified. This outcome suggests that the throughput of the screen was sufficient to cover substantial part of messages in the pool of the cancer cell transcriptomes. Target genes corresponding to multiple GSE screen hits encode a variety of proteins with diverse functions. Several genes known to be in the apoptosis pathways, DNA repair pathways and signal transduction molecules, for example, G-protein signaling components, have been captured by the screen. Interestingly, a large group of protein components of protein biogenesis machinery has been identified by the screen suggesting an indirect mode of action for such GSE screen hits resembling the effect of protein synthesis inhibitors.
Our subsequent analyses of the hits were focused on a specific group of genes encoding surface and secreted proteins since they could be considered as targets for monoclonal antibodies and protein therapeutics. Concomitant isolation of the three such genes, IGF2R, L1CAM and ITGA3, in the colon carcinoma apoptosis and breast carcinoma proliferation (Primiano et al., 2003) GSE screens not only provides additional line of evidence for validity of these cancer targets but also raises important issue of pleiotropic effects of GSEs against these targets on the both tumor cell proliferation and survival.
To further study and characterize the role of GSE screen hits in cell regulation, we generated stable cell lines expressing three selected putative GSEs. Analysis of apoptosis, plating efficiency, anchorage-independent growth and proliferation as well as stability of GFP-IRES-GSE cassette expression (Figure 2 ) reveals a low survival rate in all three cell lines; however, short-term growth curves show a clear cytostatic phenotype for SLC31A1 GSEs (Figure 2d ). Our results suggest that mechanism of SLC31A1 GSE action is directly implicated in cell proliferation. Interestingly, in agreement with our data, it was previously suggested that cell cycle inhibitors initially cause abnormal mitosis (mitotic Figure 3 Effect of IGF2R GSE on the target protein expression. HCT116 cell line with inducible expression of IGF2R GSE was incubated in the absence or presence of doxycycline (1 mg/ml) for 48 h and stained with the corresponding APC-conjugated antibody. To verify the specificity of GSE-mediated protein downregulation, cells carrying empty vector expressing tetracycline-inducible hrGFP were similarly processed and stained with the same antibodies. (a) Anti-IGF2R-APC antibody fluorescence plotted against hrGFP fluorescence. (b) IGF2R surface protein expression in total cell population. Isotype control antibody was used to determine nonspecific staining (solid gray lines, 'isotype'). Solid dark lines correspond to untreated cells ('Àdox') and broken lines correspond to doxycyline-treated cells (' þ dox') catastrophe), and subsequently induce apoptosis (Demarcq et al., 1994) . For instance, L1CAM GSEs isolated in antiproliferation GSE screen in MDA-MB-231 cells were shown to induce abnormal mitosis (Primiano et al., 2003) , while in our study L1CAM GSE induced apoptosis in HCT116 cells. The IGF2R GSE shows significant antitumor potency in vivo ( Figure 5 ) as evident from the tumor xenograft study. Our data demonstrate the feasibility of using stable GSE cell lines in xenograft tumor studies and validate the role of IGF2R in cancer. Our GSE library was constructed to bias towards antisense cDNA fragments to minimize transdominant peptides from sense cDNA fragments. Nevertheless, antisense GSEs can act not only on its cognate mRNA but also through displacement of mRNA-binding factors. Confirmation of GSE effects by siRNA inhibition studies allows filtering out potential false positive GSE hits. While siRNA may also be false positive (Jackson et al., 2003) , it is most likely that inhibition by both GSE and siRNA indicates a bona fide hit. In transient siRNA transfection studies, we have confirmed three GSE target genes, inhibition of which leads to increased apoptosis in HCT116 cells as shown by caspase 3 marker and, in case of SLC31A1, by annexin V marker. HCT116 cells transfected with siRNAs show apoptosis induction phenotypes similar to those of cell lines stably expressing inducible GSEs (Figures 2, 4 , Table 3 ). Phenotype comparison of stable GSE cell lines and stable siRNA cell lines could be a useful future study.
IGF2R gene has been previously associated with cancer since it is often mutated or epigenetically modified in various tumors (Ouyang et al., 1997; Yamada et al., 1997; Kong et al., 2000; Jamieson et al., 2003) . Our data support findings of IGF2R GSEs in proliferation screen (Primiano et al., 2003) and IGF2R antisense effect on survival of HSV1-infected cells (Zhou and Roizman, 2002) . However, IGF2R role as a death receptor for granzyme B during cytotoxic T-cell-induced apoptosis (Motyka et al., 2000) , apoptogenic effect of IGF2R overexpression in colon carcinoma SW48 cells (Souza et al., 1999) and cytoprotective effect of IGF2R ribozyme in MCF7 breast carcinoma cells (Chen et al., 2002) appear to be contradictory to our results. A recent study of IGF2R overexpression (Schaffer et al., 2003) reports opposing proliferation phenotypes in different prostate cancer cell lines offering potential explanation for such discrepancy.
We have explored a gene with no established link to cancer, SLC31A1, using siRNA and inducible GSE approaches. Interference with SLC31A1 expression via GSE and siRNA affects growth of HCT116 colon carcinoma cells. Expression of SLC31A1 mRNA was detected in a five out of five cancer cell lines tested.
In summary, using GSE methodology, we identified a number of novel genes that may represent useful targets for antibody therapies. Our results suggest requirement for the cell surface targets IGF2R, L1CAM and SLC31A1 in tumor cell growth in vitro, and suggests that IGF2R is required for xenograft tumor growth in mouse model. Our future research is aimed at functional analyses of different cancer cell lines, protein expression studies in normal/tumor tissue samples and, ultimately, development and testing of therapeutic antibody candidates.
Materials and methods
Cell lines
A549, HCT116, MALME-3M, IGROV1, MCF7, AHCN, H460 cell lines were received from DCTD Tumor Repository (National Cancer Institute, Frederick, MD, USA). FNX-Eco retrovirus packaging cell line was received from Dr Gary P Nolan (Stanford University). HCT116-16 cells are derivative of HCT116 cell line engineered to express ecotropic retrovirus receptor and LacI repressor as previously described (Chang and Roninson, 1996) . HT1080, SKOV3, MDA-MB-231 and PC3 cell lines were purchased from ATCC.
Retroviral and plasmid vector construction
Vector V99, an IPTG-regulated retroviral expression vector, was derived from pLNXCO 3 (Chang and Roninson, 1996) by incorporating the following modifications. A cDNA encoding a truncated murine Lyt-2-a 0 molecule (Nakauchi et al., 1985) was used to replace the neomycin phosphotransferase gene in pLNXCO 3 . The MCS of pLNXCO 3 was modified by subcloning a stuffer fragment that contained FseI, MluI and RsrII restriction sites, stop codons in all three reading frames downstream of the RsrII site, and M13 sequencing and unique PCR primer sites flanking the new restriction sites.
Plasmid p1674, a plasmid vector used to engineer cell lines to express tet-repressor, was constructed by replacement of the CMV promoter in pcDNA6-TR (Invitrogen, Carlsbad, CA, USA) with the EF-1a promoter (Invitrogen) by PCR. Plasmid p1704, a tet-regulated bicistronic expression vector, was constructed through a series of PCR cloning steps in which a cassette of humanized Renilla hrGFP (Stratagene, La Jolla, Photinus pyralis (firefly) luciferase (Elbashir et al., 2001a) Cell surface and secreted cancer targets MS Gelman et al CA, USA), an ECMV IRES element (BD Clontech), and a 1.5 kb EcoRI antisense c-erbB-2 cDNA fragment (Pegues and Stromberg, 1997) derived from pHER436 (ATCC) was assembled between the BamHI and NotI sites of pcDNA5/ TO (Invitrogen). The antisense c-erbB-2 cDNA in p1704 is flanked by FseI and SfiI sites to permit replacement of the cerbB-2 cDNA fragment by a putative GSE recovered from V99 using the primers p5x (5 0 -TCT GCA GCC CAG GTA AAA 
Cell surface FACS analysis
Antibodies against extracellular domains of IGF2R (Santa Cruz Biotech, Santa Cruz, CA, USA), XPR1 (Santa Cruz Biotech), L1CAM (clone UJ127, Labvision, Fremont, CA, USA) and COL4A2 (Chemicon, Temeluca, CA, USA) were obtained from commercial sources. Downmodulation of IGF2R protein by siRNA in MDA-MB-231 cells was studied using FITC-conjugated anti-IGF2R antibody (clone MEM-238, Serotec, Raleigh, NC, USA). Labeled cell populations were analysed by FACS analysis (FACSCalibur, BD Bioscience, San Jose, CA, USA).
Random fragment cDNA library construction
Total RNA was harvested from eight cell lines, A549, HCT116, HT1080, MALME-3M, H460, MCF-7, IGROV1 and ACHN, using RNeasy Mini Kits (Qiagen, Valencia, CA, USA). Equal amounts from each cell line were pooled and used for poly(A þ ) normalization as follows. Driver cDNA was synthesized by reverse transcription (Omniscript, Qiagen) of poly(A þ ) RNA captured from 100 mg of pooled total RNA using Oligotex oligo-dT beads (Qiagen), with the bead-bound oligo(dT) serving as primer. RNA was removed from the driver cDNA by heat denaturation and extensive washing. Next, bead-bound driver cDNA was hybridized with 50 mg of pooled total RNA for 10 min at 371C. The supernatant above the driver beads was collected, and normalized poly(A þ ) RNA was extracted from the recovered supernatant using oligo-dT beads. The extent of normalization was evaluated by semiquantitative RT-PCR analysis for three genes (b-actin, c-myc and E2F1) (Gudkov and Roninson, 1997) and was judged sufficient if the signals for each gene reached a maximum between 25 and 30 cycles. The normalized poly(A þ ) fractions were boiled for 3 min to randomly fragment the RNA, and RNA was reverse transcribed into cDNA (Gubler and Hoffman, 1983 ) using the SuperScript double-strand cDNA synthesis kit (Invitrogen) and the primer AscN 10 (5 0 -ACC CCT CAC TTG GCG CGC CN 10 -3 0 ). Double-strand 
Target gene downmodulation
A -50% or greater decrease in percent GFP-positive cells in course of 2-week doxycycline treatment (Figure 2a) , B -1.5-fold or greater increase in percent of caspase 3-positive cells as compared to vector control (in presence of doxycycline) (Figure 2b ), C -25% or greater decrease in cell proliferation of caspase 3-positive cells compared to vector control (Alamar blue assay, 48 h) (Figure 2d ), D -twofold or greater decrease in soft agar colony formation as compared to vector control in presence of doxycycline (Figure 2e ), E -inhibition of tumor growth in xenograft mouse model ( Figure 5 ). b Decrease in protein level detected by immunocytometry, number of hours post doxycycline induction prior to the measurement is shown in parentheses (Figure 3) . c F -1.5-fold or greater increase in percent of caspase 3-positive cells as compared to cells transfected with scrambled siRNA (Figure 4a ), G -1.5-fold or greater increase in percent of annexin V-positive cells as compared to cells transfected with scrambled siRNA (Figure 4a ). Cell surface and secreted cancer targets MS Gelman et al random fragment cDNAs were ligated to linkers produced by annealing oligonucleotides L1 (5 0 -GGC TGG GTG TGG CGG ACC G-3 0 ) and L2 (5 0 -CGG TCC GCC ACA CCC AG-3 0 ). Random fragment inserts were amplified by 22 cycles of PCR, using the primers P1 (5 0 -ACC CCT CAC TTG GCG CGC C-3 0 ) and P2 (5 0 -GGC TGG GTG TGG CGG ACC G-3 0 ), and the PCR products digested with AscI and RsrII restriction endonucleases. Vector was prepared by digesting V99 with MluI and RsrII restriction endonucleases, random fragment cDNAs were ligated to 900 ng of digested vector, and the ligation products were transformed into ElectroMax DH10B bacterial cells (Invitrogen). A portion of the transformation was serially diluted and plated to estimate library complexity, while the balance of the transformations were used to seed LB cultures grown at 301C for 16 h in a rotary shaker at 300 r.p.m. Library plasmid DNA was prepared using DNA Maxiprep kits (Qiagen). Insert diversity was evaluated by gel mobility analysis and sequencing of PCR products was amplified directly from the bacterial colony (Hofmann and Brian, 1991) using primers M13F17 (5 0 -GTA AAA CGA CGG CCA GT-3 0 ) and p6x (5 0 -TCT GCA GCC CAG GTA AAA TTC GCT AGC CTC TAG T-3 0 ). The final transcriptomewide GSE plasmid library had a complexity of 4 Â 10 7 independent colonies or greater, with over 95% containing an insert, with an average size of 0.4 kbp.
Selected GSE library construction and analysis
Putative GSEs were recovered from the integrated proviral DNA after each round of functional selection by PCR amplification using Thermozyme DNA polymerase (Invitrogen) and the Zea mays-derived primer pair p5 Â (5 0 -TCT GCA GCC CAG GTA AAA TTC GCT AGC CTC TAG T-3 0 ) and p6x (5 0 -GAG GAA CAA GGA AAG CTG AAT ACA CGA CCC GTG AT-3 0 ). Recovered PCR products from 0-, 24-, 48-and 72-h apoptotic cell harvesting time points were quantitated and equal amounts of PCR products from each time point were mixed. Pooled PCR products were digested with FseI and RsrII, subcloned into 150 ng V99 digested with FseI and RsrII, and the resultant selected libraries characterized, propagated, and purified as described above. Equal number of recombinant clones corresponding to 0-, 24-, 48-and 72-h time points were pooled to prepare select GSE library. For each select GSE library, over 95% of the colonies had inserts. Complexities of GSE libraries used in the second and third rounds of screen were 5.0 Â 10 6 and 1.0 Â 10 6 independent clones or greater, respectively. The final selected GSE library constructed after three iterations of functional selection in HCT116-16 cells had a complexity of 1 Â 10 6 independent clones or greater, with an average insert size of 0.24 kbp. Sequencing was performed on DNA harvested from individual colonies in this library, and the BLAST algorithm was used to search the GenBank sequence database for similarities.
siRNA transfection
The siRNA complexes (Table 2 ) used in these studies were designed to according to the set of guidelines established by the Tuschl laboratory (Elbashir et al., 2001b, c) . Single strands of complementary 21-nucleotide RNA with an overhang of two deoxynucleotides on the 3 0 termini were synthesized (Genset, Evry, France) for each of the targets. Each strand was independently resuspended in annealing buffer (10 mM TrisHCl, pH 8.3; 0.2 mM MgCl 2 ; 50mM KCl) at a final concentration of 20 mM. To generate annealed siRNA duplexes, equivalent volumes of each RNA strand were combined and heated to 901C for 1 min in a heat block which was then turned off and allowed to cool to room temperature. HCT116 cells were plated the day before transfection with antibiotic-free media into a six-well plate at a density of 5 Â 10 4 cells per well and each well was transfected with 5 ml of 20 mM siRNA duplex mixture using 5 ml of Oligofectamine reagent (Invitrogen). Controls for the transfections included the Oligofectamine-mediated transfection of an equivalent quantity of a duplex with sequences directed against firefly luciferase or a nonspecific control duplex, a sequence that was determined to be not present in mammalian systems by BLAST analysis. An additional control included Oligofectamine-mediated transfection of an equivalent volume of the annealing buffer. Transfection conditions were optimized to ensure at least 77% efficiency in HCT116 cells. Specific siRNA-mediated effects on targeted genes were confirmed by a minimum of two independent experiments.
Stable cell lines expressing inducible GSE
Stable cell lines with tetracycline-inducible expression of individual GSEs were generated by transfection of the p1704 vector carrying bicistronic hrGFP-IRES-GSE cassette into HCT116-TRex8 clonal cell line stably expressing tetracycline repressor (TetR) protein. TetR protein was expressed from pcDNA6/TR vector (T-RExt System, Invitrogen). At 48 h after transfection, cells were replated into selection medium containing 200 mg/ml hygromycin (Invitrogen) and 10 mg/ml blasticidin S (Invitrogen). After 10-14 days of selection, 10-30 selected colonies were pooled, expanded and hrGFP-IRES-GSE expression was induced by doxycycline (BD Clontech) treatment (1 mg/ml, 15 h). Induced cells were sorted (FACSVantage, BD Bioscience) to isolate GFP-positive populations (SPs) at over 95% purity, which were further expanded in the absence of doxycycline. Inducible expression of hrGFP-IRES-GSE cassette was confirmed by FACS and real-time PCR analysis. In the case of IGF2R GSE-expressing cells used for xenograft studies (see below), antibiotic-resistant cells were sorted by FACS for GFP expression in the absence of doxycycline induction: the resulting refined population (RP) was expanded and used for in vivo studies.
Apoptosis and proliferation assays
Apoptosis induction in stable cell lines with inducible GSE expression and in siRNA-transfected cells was measured by the active caspase 3 assay. Stable cell lines were plated in six-well dishes at 50 000 cells per well and GSE expression was induced by addition of 1 mg/ml doxycycline at 24 h after plating. Following 72 h of doxycycline treatment cells were harvested, floating and attached cells were combined, fixed in Cytofix/ Cytoperm solution (BD Pharmingen) and stained with PEconjugated monoclonal rabbit antiactive caspase 3 antibody (68655X, BD Pharmingen). Data were collected by FACS (FACSCalibur, BD Bioscience) and analysed using CellQuest (Beckton Dickinson) software. SiRNA-transfected cells were divided in halves at 72 h post-transfection. One half was analysed by active caspase 3 assay as described above, another half was analysed by annexin V staining cells using GuavaNexint kit (Guava Technologies, Hayward, CA, USA). Briefly, cells were resuspended in 50 ml of cold Nexin buffer containing annexin V-PE and 7-AAD. After incubating for 20 min at 41C, samples were washed with cold Nexin buffer and resuspended in this buffer for analysis on the Guava PCA system (Guava Technologies).
Effect of inducible GSE expression on proliferation of HCT116 cells was measured by Alamar blue assay. Briefly, cells were plated in 24-well dish at 10 000 cells per well in two sets of triplicates. After 16 h, one set of cells was grown in the absence of doxycycline treatment while another set of cells was treated with 1 mg/ml doxycycline to induce GSE expression for up to 48 h. At 0-, 24-and 48-h time points, cells were incubated with Alamar Bluet reagent (Biosource International, Camarillo, CA, USA) for 4 h, and fluorescence emission was measured at 595 nm on Analystt HT (Molecular Devices, Sunnyvale, CA, USA). The 0-h time point data was used to determine the plating efficiency.
Soft agar assays were performed to evaluate the effect of doxycycline-induced GSE expression on anchorage-independent cancer cell growth. HCT-116-derived cell lines with tetracycline-inducible expression of IGF2R, SLC31A1 GSEs as well as ErbB2as control were resuspended at 5000 cells in 1.5 ml of warm media containing 0.35% BactoAgar (Difco Laboratories, Detroit, MI, USA), and doxycycline was added to final concentration of 1 mg/ml. Untreated control cells were processed similarly but without the addition of doxycycline. Cells were plated on top of 3 ml of 0.5% agar in 6 cm dishes in triplicates. Plates were incubated for 3 weeks in humidified chamber at 371C, 5% CO 2 . Cell colonies were first examined by fluorescence microscopy for GFP expression, then visualized by staining with 0.005% p-iodonitrotetrazolium violet in 50% methanol for 1 h at room temperature, image-captured by scanning and images were processed using Adobe Photoshop software (Adobe Systems, San Jose, CA, USA).
RNA preparation and microarray hybridization
Total RNA was harvested from 4 Â 10 6 cells using a High Pure RNA isolation kit (Roche Applied Science, Indianapolis, IN, USA) according to the manufacturer's instructions. A pool of 10 human cell line RNAs (Universal RNA; Stratagene, Carlsbad, CA, USA) was used as a reference in all array hybridizations. Quality control of the total RNA was facilitated by the use of a microcapillary electrophoresis system (Agilent 2100 Bioanlyzer, Agilent, Palo Alto, CA, USA). For each array, amino-allyl labeled single-stranded cDNA was synthesized from 10 mg of total RNA or universal RNA using a commercially available kit (Agilent Fluorescent Direct Label Kit; Agilent Technologies, Palo Alto, CA, USA) according to the manufacturer's instructions, except that a dNTP mix containing 5-[3-Aminoallyl]-2 0 -deoxyuridine 5 0 -triphosphate (AA-dUTP; Sigma-Aldrich) was used (final concentration: 100 mM dATP, dCTP, dGTP; 50 mM dTTP, AA-dUTP). Amino-allyl labeled cDNA was purified using QIAquick PCR columns (Qiagen, Valencia CA, USA) and coupled to either N-hydroxysuccinimidyl-esterified Cy3 or Cy5 dyes (Cy-Dye mono-functional NHS ester; Amersham, Piscataway NJ, USA). Dye-conjugated cDNAs were purified from free dye using the CyScribe GFX purification kit (Amersham), and used as targets for hybridization to 70-mer oligonucleotide microarrays (Agilent) custom manufactured to contain probes for 3531 different cell-surface and secreted genes. Arrays were hybridized for 16 h at 601C using an Agilent In Situ Hybridization Kit as per the manufacturer's instructions, washed 10 min in 6 Â SSC, 0.005% Triton X-102 at 221C, 0.1 Â SSC, 0.005% Triton X-102 for 10 min at 41C, dried under a stream of nitrogen, and scanned with an Agilent Microarray Scanner. Hybridization signals were extracted with Agilent Feature Extraction Software version 7.1 (Agilent) which yielded the median of all pixel intensities for each feature. To facilitate comparison of gene expression levels across cell lines, the intensity of the signal for a specific oligonucleotide probe was normalized to the average intensity of the signal from the two b-2-microglobulin probes for the given cell line.
Mouse xenograft studies
Mouse xenograft studies tested the in vivo tumor growth of parental HCT116 cell lines expressing the TetR protein only (control), or IGF2R-GSE and ErbB2-AS in athymic nude mice in the presence or absence of doxycycline. Female athymic nude mice (Charles River Laboratories, Wilmington, MA, USA) were implanted subcutaneously with 10 7 HCT116 cloned tumor cells. At 6-7 days after implant, 14-17-week-old mice bearing established HCT116 cloned tumors were sorted into two groups of five mice each. For each study, Group 1 mice were not treated and Group 2 mice received 1 mg/ml of doxycycline in their drinking water. Tumors were measured using calipers twice a week, and tumor volumes were calculated. Animals were euthanized when their tumors reached the predetermined 1500 mm 3 end point tumor volume. Study durations were 33-48 days, and at the end of each study all remaining animals were euthanized.
